Aaron Roebuck has nearly 30 years of experience in respiratory and cardiopulmonary medicine, particularly in medical technology development. He recently served as Senior Director of Clinical Sciences, National Director of Customer Engagement and Director of Application Engineering and Clinical Education at Vero Biotech, where he focused on next-generation drug delivery systems. He was previously at Mallinckrodt Pharmaceuticals in various clinical and research roles including Clinical Specialist, National Clinical Team Manager, Investigational Research Coordinator, and Device Design Lead. Aaron also taught as an adjunct professor in respiratory care at Washington Adventist University. He has built and managed large teams, led clinical trials, raised capital, and contributed to FDA submissions, significantly impacting his field through research, education, and management.

Dr. Victor van Berkel, MD, PhD is a Professor of Surgery in the Department of Cardiovascular and Thoracic Surgery at the University of Louisville, as well as Chief of the Division of Thoracic Surgery and is currently the vice-chair of the Department. He is a co-investigator for several oncologic clinical trials through the Brown Cancer Center, and sits on two FDA panels that deal with the approval of medical devices. In addition to his clinical practice, he has an active research lab - his research on the use of breath analysis to identify lung cancer led to him being a cofounder of Breath Diagnostics, Inc.

Dr. Michael H. Nantz currently serves as the Professor and Chair of the Department of Chemistry at the University of Louisville. Dr. Nantz has made significant contributions to the world of science and academia. Dr. Nantz's research expertise spans various areas, including cationic lipids and polymers for gene delivery, peptide-based prodrugs for cancer chemotherapeutics, applications of nanoparticle-peptide conjugates, and, of course, breath analysis research such quantitative analysis of exhaled carbonyl compounds. He has a prolific publication record, with many notable publications and is a contributor to several patents and licenses related to his research, including those in the field of cationic transport reagents, polyfunctional cationic cytofectins, breath analysis, and more. His innovations have had a significant impact on various areas of science and technology.

Xiao-An (Sean) Fu is a Professor of Chemical Engineering at the University of Louisville. His current research interests include chemical microsensors, microreactors, breath analysis for development of a noninvasive diagnostic tool for detection of early lung cancer, trace gas detection, active tuberculosis and other pulmonary diseases, analysis of neurotransmitter, and advanced semiconductor thin films for integrated circuit and solar cell applications. He has published more than 60 papers in refereed journals and conference proceedings, and has received three U.S. patents. He was a key contributor to a number of research projects funded by DARPA and NASA including SiC MEMS and SiC JFET-based integrated circuits for high temperature applications. He invented a process for deposition of low stress polycrystalline SiC suitable as MEMS structure materials.

Dr. Bousamra is a thoracic (chest) surgeon with Ascension Michigan in Detroit, Warren, and Southfield, specializing in the care of patients with lung cancer, esophageal cancer, and in the full spectrum of malignant and benign non-cardiac diseases of the chest. He is also chief of thoracic surgery in SE Michigan and is responsible for the development and implementation of a comprehensive lung cancer program focusing on early detection. A graduate of University of Michigan Medical School and a member of the American Association for Thoracic Surgery, he has authored over 50 peer-reviewed publications and holds several patents on methods to detect cancer.

Ivan Lo is the founder of Wealth Stream Capital Corp, a family office that invests in private and public companies across various sectors. WSCC was formed as a result of the seed and early-stage investments Ivan Lo has made, which have led to multiple exits and companies that have surpassed unicorn valuations. Ivan has led multiple strategic financing initiatives, and has been instrumental in the success of numerous private and public companies, playing a key role in the structure and financing of companies across various sectors. He has funded over 100 private and public companies who collectively have raised over $1 billion.

Phillip B. Douglas has 40 years of experience as a seasoned and innovative leader who has management and board experience which spans diverse organizational settings and industries. In addition to serving as a Director of Breath Diagnostics, Mr. Douglas currently serves on the Board of Directors of Oceans Healthcare, PartnerCare, Ernest Healthcare, The Ear Nose Throat & Plastic Surgery Associates (“ENTPSA”), Palmetto Technology Group (“PTG”) and Volta Inc. Previously Phil was the Executive Chairman of KureSmart Pain Management and Chairman and CEO of LifeCare Health Partners, which operated 25 locations in 9 states and experienced significant revenue and earnings growth under Mr. Douglas’ leadership. Mr. Douglas previously held senior executive positions with Humana and United Healthcare. Mr. Douglas is a graduate of the University of Kentucky and was a CPA with Price Waterhouse Coopers.

Dr. Rich is currently the Cleveland Clinic’s Chairman of Operations and Strategy for the Sydell and Arnold Miller Family Heart & Vascular Institute. He previously served as the Surgical Director of the Sentara Cardiac Research Institute, as past President of the Society of Thoracic Surgeons and held leadership positions within the National Quality Forum (NQF). In addition, Dr. Rich served as the Director of the Center for Medicare at the Centers for Medicare and Medicaid Services (CMS). He testified four times before Congress and has served on Federal Advisory Committees for CMS as well as the FDA Circulatory System Devices Panel of the Medical Devices Advisory Committee.

Logan Zechella is a University of Louisville graduate and former Fulbright Scholar with an extensive background in research and healthcare. He has a passion for innovation and technology with a drive to create new technological solutions to today’s most pressing healthcare challenges. In his role at Breath Diagnostics, he is an integral part of the collaborative effort in developing and testing the OneBreath™ breath analysis system for lung cancer screen and diagnosis.

Mr. Johnson is seasoned executive of over 30 years. His extensive career experience covers project management and controls, accounting, corporate finance and strategy. Dean is both a Certified Public Accountant and a Certified Management Accountant, handily serving international companies. Prior to joining Breath Diagnostics, he worked with wide-ranging industry groups, including renewable and traditional energy, tax services, human resources placement, and holistic medicine. In these positions, Mr. Johnson mentored staff, managed reporting, cost controls, scheduling, cost estimating, and progress reporting, as well as project setup and closeout for over $15 billion in projects across the entire gamut of the energy industry, as well as supporting and managing $26 billion of projects across three divisions at one of Canada’s largest energy companies.

Stefan Weigl studied Electrical and Microsystems Engineering with a focus on analytical chemistry and optical sensor technology at the University of Applied Sciences in Regensburg, Germany. He completed his doctorate in the field of breath analysis using photoacoustic spectroscopy (PAS) to measure human breath acetone at the University of Regensburg in 2021. He is author and co-author of several peer-reviewed papers regarding photoacoustic spectroscopy and breath analysis. From 2016 until 2023 he led the breath analysis research group in the Sensorik-Applikation Centre in Regensburg investigating the detection of acetone and other breath components employing PAS. He edited and partially authored the book Breath Analysis – An Approach for Smart Diagnostics, published within Springer Link in 2022. Since October 2023 he is employed as a technology scout for a globally acting automotive supplier scouting and reviewing the technologies of tomorrow.